BofA/Merrill Lynch Downgrades ResMed (RMD) to Neutral
Tweet Send to a FriendGet Alerts RMD Hot Sheet
Price: $47.66 -0.42%
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade RMD Now!
BofA/Merrill Lynch downgraded ResMed (NYSE: RMD) from Buy to Neutral.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $34.11 yesterday, with a 52 week range of $23.37-$35.32.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $34.11 yesterday, with a 52 week range of $23.37-$35.32.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Numera Social Platform Powers New Patient Engagement Program Launched by ResMed
- Goldman Sachs Removes Williams Companies (WMB) from CL Buy List; Downgrades Williams Partners (WPZ) to Neutral
- Wells Fargo Cuts Comerica (CMA) and First Horizon National (FHN) to Underperform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Merrill Lynch, Bank of America
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
